← Open Payments lookup

KELSEY USSELMANN: Open Payments

NPI 1417510082 · WOODLAND HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$811 in 32 payments from 10 companies in 2025. Trend: 2023 $417 · 2024 $921 · 2025 $811

Food & beverage: $811
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$298
GENZYME CORPORATION9$206
CSL Behring3$72
GlaxoSmithKline, LLC.2$48
Novartis Pharmaceuticals Corporation2$43
ARS Pharmaceuticals Operations, Inc.2$42
Cycle Pharmaceuticals Inc1$27
Organon LLC1$27
Regeneron Healthcare Solutions, Inc.1$26
Takeda Pharmaceuticals U.S.A., Inc.1$21

Products named: FASENRA, DUPIXENT, AYVAKIT, Rhapsido, NEFFY, Andembry, TEZSPIRE, Haegarda.

Industry payments across CA — which companies pay providers there.